This test is most useful if any of these apply to you.
If you have ever had a reaction to latex gloves, balloons, or medical equipment, the question is not just whether you are sensitized but what exactly your immune system is reacting to. Latex is made of many different proteins, and knowing which ones trigger your IgE (immunoglobulin E, the antibody behind allergic reactions) helps clarify whether you have true clinical allergy or a quieter form of sensitization that may never cause symptoms.
This test measures IgE antibodies in your blood that specifically recognize Hev b 11, one of about a dozen named latex proteins from the rubber tree Hevea brasiliensis. It is part of a broader approach called component-resolved diagnostics, which breaks latex allergy testing down protein by protein rather than treating latex as a single allergen.
Your test result reflects the amount of IgE antibodies circulating in your blood that bind to Hev b 11, a specific protein from natural rubber latex. IgE antibodies are produced by class-switched B cells (a type of immune cell that makes antibodies), and their presence signals that your immune system has been primed by prior exposure to that protein.
Hev b 11 is one of several recombinant latex allergens used in component testing. Other latex components you may see on a full panel include Hev b 1, 3, 5, 6.01, 6.02, and 8. Each one tells a slightly different story about your sensitization profile, and Hev b 11 specifically tends to show up in people who already have a broader atopic background (a tendency toward allergic conditions like hay fever, eczema, or asthma).
This is a Tier 3 marker. It is used primarily in research and specialty allergy settings, and there are no universally standardized cutpoints that define a clinically meaningful level of Hev b 11 IgE on its own. Its value comes from being read alongside other latex components, not as a standalone verdict.
In 210 children with spina bifida (a group with heavy surgical latex exposure), IgE positivity to Hev b 11 occurred in 32% of children with latex symptoms. But sensitization was more frequent to Hev b 1 and Hev b 3, and Hev b 11 was part of the sensitization profile rather than the leading marker of symptomatic allergy.
In children without spina bifida, those sensitized to Hev b 8, Hev b 9, or Hev b 11 tended to be atopic, meaning Hev b 11 IgE often appears within a broader allergic background rather than as a primary clinical driver. In latex-fruit syndrome (a cross-reaction between latex and certain fruits like banana, avocado, kiwi, or chestnut), sera recognized Hev b 6.02 but not Hev b 11, suggesting Hev b 11 is not the marker to look for when investigating latex-fruit reactions.
In workers with suspected latex-induced occupational asthma, IgE to Hev b 11 was more frequent in those with a positive inhalation challenge than in those with a negative challenge. That said, the strongest predictors of true occupational asthma in this group were high IgE to Hev b 5 combined with Hev b 6.01 or 6.02.
This pattern matters if you work in healthcare, dentistry, food service, manufacturing, or any setting with frequent glove use or aerosolized latex protein exposure. Hev b 11 IgE alone will not confirm or rule out occupational latex asthma, but it can add detail to a panel-based workup.
Having IgE in your blood to a latex protein means your immune system has been primed. It does not automatically mean you will react when exposed. Across allergy testing in general, only about half of IgE-sensitized individuals develop symptomatic disease, and latex is no exception.
This distinction is the central reason component testing exists. Whole-latex IgE assays are sensitive (around 94% in one study of suspected occupational asthma) but less specific (around 48% at standard cutoffs). Many people test positive without ever having a clinical reaction. Component panels that break the signal apart into Hev b 1, 3, 5, 6, 8, and 11 help separate true allergy from harmless sensitization, especially when standard latex IgE and skin tests disagree.
Allergen-specific IgE levels can shift over time as your exposure changes, your immune system matures, or you undergo treatment. A single Hev b 11 result is a snapshot, not a verdict. If you are actively reducing latex exposure, changing jobs, or undergoing immunotherapy for another allergen, your component IgE profile may change.
Get a baseline if you have a personal or occupational reason to investigate latex allergy. If you are tracking sensitization over time, especially in occupational settings where exposure is changing, repeat testing at least annually is reasonable. Pair component IgE testing with a clinical history. Numbers in isolation are far less useful than numbers interpreted alongside real-world reactions.
A few things can blur the interpretation of a Hev b 11 IgE result.
A positive Hev b 11 IgE should not be interpreted in isolation. The most useful next step is to look at the full latex component panel, especially Hev b 5, Hev b 6.01, and Hev b 6.02, which carry the strongest signal for clinically important latex allergy and peri-operative anaphylaxis risk.
If you have symptoms that fit latex allergy (hives on contact, swelling, wheezing, anaphylaxis during medical procedures), see an allergist or immunologist who can integrate your component results with skin testing, clinical history, and if needed, provocation testing. If you have a positive Hev b 11 result but no symptoms and your other latex component IgEs are low or negative, this may simply reflect atopic sensitization rather than a clinical allergy. Either way, the appropriate response is investigation by a specialist, not a presumption of allergy or its absence.
Evidence-backed interventions that affect your Latex (Hev b 11) IgE level
Latex (Hev b 11) IgE is best interpreted alongside these tests.
Latex (Hev b 11) IgE is included in these pre-built panels.